$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 13 14 15 16 17 18 19 20 21 ... 21 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.86 | 3,820 | 56,768 | 159,739 | 163.6 K to 159.7 K (-2.34 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.71 | 4,829 | 71,043 | 163,559 | 168.4 K to 163.6 K (-2.87 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.94 | 12,974 | 193,870 | 168,388 | 181.4 K to 168.4 K (-7.15 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.86 | 179,644 | 2,669,654 | 7,511,046 | 7.7 M to 7.5 M (-2.34 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.71 | 227,071 | 3,340,623 | 7,690,690 | 7.9 M to 7.7 M (-2.87 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.94 | 610,072 | 9,116,306 | 7,917,761 | 8.5 M to 7.9 M (-7.15 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.00 | 1,856 | 25,980 | 271,646 | 273.5 K to 271.6 K (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.00 | 956 | 13,384 | 273,502 | 274.5 K to 273.5 K (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.08 | 6,053 | 85,234 | 274,458 | 280.5 K to 274.5 K (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.09 | 3,938 | 55,476 | 280,511 | 284.4 K to 280.5 K (-1.38 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.00 | 1,239 | 17,344 | 181,362 | 182.6 K to 181.4 K (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.00 | 638 | 8,932 | 182,601 | 183.2 K to 182.6 K (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.08 | 4,041 | 56,903 | 183,239 | 187.3 K to 183.2 K (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.09 | 2,629 | 37,036 | 187,280 | 189.9 K to 187.3 K (-1.38 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.00 | 22,751 | 318,468 | 3,330,071 | 3.4 M to 3.3 M (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.00 | 11,711 | 163,953 | 3,352,822 | 3.4 M to 3.4 M (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.08 | 74,201 | 1,044,847 | 3,364,533 | 3.4 M to 3.4 M (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.09 | 48,266 | 679,938 | 3,438,734 | 3.5 M to 3.4 M (-1.38 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 58,262 | 815,551 | 8,527,833 | 8.6 M to 8.5 M (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 29,988 | 419,829 | 8,586,095 | 8.6 M to 8.6 M (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.08 | 190,020 | 2,675,729 | 8,616,083 | 8.8 M to 8.6 M (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.09 | 123,602 | 1,741,218 | 8,806,103 | 8.9 M to 8.8 M (-1.38 %) |
| Aug 11 2010 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Sell | S | 14.00 | 1,842 | 25,784 | 269,649 | 271.5 K to 269.6 K (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Sell | S | 14.00 | 947 | 13,258 | 271,491 | 272.4 K to 271.5 K (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Sell | S | 14.08 | 6,009 | 84,615 | 272,438 | 278.4 K to 272.4 K (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Sell | S | 14.09 | 3,907 | 55,039 | 278,447 | 282.4 K to 278.4 K (-1.38 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | M | 6.15 | 94,960 | 584,004 | 0 | |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.89 | 8,900 | 123,621 | 4,500 | 13.4 K to 4.5 K (-66.42 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.92 | 10,600 | 147,552 | 13,400 | 24 K to 13.4 K (-44.17 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.87 | 7,689 | 106,646 | 24,000 | 31.7 K to 24 K (-24.26 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.82 | 492 | 6,799 | 31,689 | 32.2 K to 31.7 K (-1.53 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.91 | 7,800 | 108,498 | 32,181 | 40 K to 32.2 K (-19.51 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.81 | 1,360 | 18,782 | 39,981 | 41.3 K to 40 K (-3.29 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.88 | 25,885 | 359,284 | 41,341 | 67.2 K to 41.3 K (-38.50 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.80 | 600 | 8,280 | 67,226 | 67.8 K to 67.2 K (-0.88 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.83 | 1,499 | 20,731 | 67,826 | 69.3 K to 67.8 K (-2.16 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.90 | 13,430 | 186,677 | 69,325 | 82.8 K to 69.3 K (-16.23 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.86 | 6,000 | 83,160 | 82,755 | 88.8 K to 82.8 K (-6.76 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.85 | 6,200 | 85,870 | 88,755 | 95 K to 88.8 K (-6.53 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Sell | S | 13.84 | 4,505 | 62,349 | 94,955 | 99.5 K to 95 K (-4.53 %) |
| Aug 10 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Buy | M | 6.15 | 94,960 | 584,004 | 99,460 | 4.5 K to 99.5 K (+2,110.22 %) |
| Aug 10 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 14.08 | 1,100 | 15,488 | 5,343 | 6.4 K to 5.3 K (-17.07 %) | |
| Aug 10 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 14.05 | 9,818 | 137,943 | 6,443 | 16.3 K to 6.4 K (-60.38 %) | |
| Aug 10 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 14.07 | 2,200 | 30,954 | 16,261 | 18.5 K to 16.3 K (-11.92 %) | |
| Aug 10 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 14.06 | 2,500 | 35,150 | 18,461 | 21 K to 18.5 K (-11.93 %) | |
| Jul 08 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 7.09 | 10,895 | 77,246 | 0 | |
| Jul 08 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 5.46 | 14,247 | 77,789 | 0 | |
| Jul 08 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 7.09 | 10,895 | 77,246 | 289,707 | 278.8 K to 289.7 K (+3.91 %) |
| Jul 08 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 5.46 | 14,247 | 77,789 | 278,812 | 264.6 K to 278.8 K (+5.39 %) |
| Jul 06 2010 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | P | 10.24 | 2,000 | 20,480 | 8,500 | 6.5 K to 8.5 K (+30.77 %) |
| Jul 06 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 10.43 | 5,697 | 59,420 | 264,565 | 258.9 K to 264.6 K (+2.20 %) |
| Jul 06 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 10.42 | 4,303 | 44,837 | 258,868 | 254.6 K to 258.9 K (+1.69 %) |
| Jun 21 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 5.97 | 72,917 | 435,314 | 0 | |
| Jun 21 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 6.27 | 25,000 | 156,750 | 0 | |
| Jun 21 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Sell | S | 13.15 | 97,917 | 1,287,609 | 0 | 97.9 K to 0 (-100.00 %) |
| Jun 21 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 5.97 | 72,917 | 435,314 | 97,917 | 25 K to 97.9 K (+291.67 %) |
| Jun 21 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 6.27 | 25,000 | 156,750 | 25,000 | 0 to 25 K |
| May 25 2010 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | A | 12.46 | 18,334 | 228,442 | 18,334 | |
| May 25 2010 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | A | 12.46 | 35,000 | 436,100 | 35,000 | |
| May 25 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 12.46 | 3,473 | 43,274 | 3,473 | |
| May 25 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 12.46 | 21,527 | 268,226 | 21,527 | |
| May 20 2010 | INCY | INCYTE CORP | ARIKO BARRY A | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | NIBLACK JOHN F | Director | Option Exercise | A | 13.34 | 20,000 | 266,800 | 20,000 | |
| May 20 2010 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 13.34 | 167 | 2,228 | 167 | ||
| May 20 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 13.34 | 5,833 | 77,812 | 5,833 | ||
| May 20 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| May 20 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 13.34 | 834 | 11,126 | 834 | |
| May 20 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 13.34 | 29,166 | 389,074 | 29,166 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 4.19 | 20,000 | 83,800 | 15,000 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 12.94 | 20,000 | 258,800 | 0 | 20 K to 0 (-100.00 %) |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 4.19 | 20,000 | 83,800 | 20,000 | 0 to 20 K |
| Jan 25 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 9.41 | 156,487 | 1,472,543 | 156,487 | |
| Jan 25 2010 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 9.41 | 13,513 | 127,157 | 13,513 | |
| Jan 25 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 9.41 | 72,930 | 686,271 | 72,930 | |
| Jan 25 2010 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 9.41 | 12,070 | 113,579 | 12,070 | |
| Jan 25 2010 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 9.41 | 72,930 | 686,271 | 72,930 | |
| Jan 25 2010 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 9.41 | 12,070 | 113,579 | 12,070 | |
| Jan 25 2010 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 9.41 | 72,930 | 686,271 | 72,930 | |
| Jan 25 2010 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 9.41 | 12,070 | 113,579 | 12,070 | |
| Jan 25 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 9.41 | 72,930 | 686,271 | 72,930 | |
| Jan 25 2010 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 9.41 | 12,070 | 113,579 | 12,070 | |
| Jan 25 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 9.41 | 19,406 | 182,610 | 19,406 | ||
| Jan 25 2010 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 9.41 | 14,594 | 137,330 | 14,594 | ||
| Jan 25 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 9.41 | 72,930 | 686,271 | 72,930 | |
| Jan 25 2010 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 9.41 | 12,070 | 113,579 | 12,070 | |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 72,700 | 684,107 | 72,700 | |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 12,300 | 115,743 | 12,300 | |
| Jan 25 2010 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 9.41 | 72,700 | 684,107 | 72,700 | |
| Jan 25 2010 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 9.41 | 12,300 | 115,743 | 12,300 | |
| Jan 08 2010 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Sell | S | 10.90 | 22,000 | 239,800 | 38,137 | 60.1 K to 38.1 K (-36.58 %) |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 33,130,000 | 371,668,905 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 42,509,000 | 476,887,217 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | A | 8.78 | 124,687,000 | 1,094,751,860 | 124,687,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Grant | A | 6.75 | 1,848,200 | 12,475,350 | 8,929,705 | 7.1 M to 8.9 M (+26.10 %) |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | D | 11.22 | 3,597,000 | 40,352,945 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | D | 11.22 | 15,055,000 | 168,894,518 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | A | 8.78 | 29,593,000 | 259,826,540 | 29,593,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | D | 11.22 | 989,000 | 11,095,097 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | D | 11.22 | 878,000 | 9,849,843 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | A | 8.78 | 3,478,000 | 30,536,840 | 3,478,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Grant | A | 6.75 | 101,506 | 685,166 | 282,354 | 180.8 K to 282.4 K (+56.13 %) |
| Sep 28 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | D | 11.22 | 470,000 | 5,272,695 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | D | 11.22 | 294,000 | 3,298,239 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | A | 8.78 | 2,054,000 | 18,034,120 | 2,054,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 6.75 | 50,294 | 339,485 | 189,909 | 139.6 K to 189.9 K (+36.02 %) |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | D | 11.22 | 64,000 | 717,984 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | D | 11.22 | 335,000 | 3,758,198 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | A | 8.78 | 188,000 | 1,650,640 | 188,000 | |
| May 21 2009 | INCY | INCYTE CORP | NIBLACK JOHN F | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| May 21 2009 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| May 21 2009 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| May 21 2009 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| May 21 2009 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| May 21 2009 | INCY | INCYTE CORP | ARIKO BARRY A | Director | Option Exercise | A | 2.80 | 20,000 | 56,000 | 20,000 | |
| Mar 10 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.10 | 9,400 | 19,740 | 254,565 | 245.2 K to 254.6 K (+3.83 %) |
| Mar 10 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.10 | 10,600 | 22,260 | 245,165 | 234.6 K to 245.2 K (+4.52 %) |
| Mar 05 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.20 | 8,840 | 19,448 | 234,565 | 225.7 K to 234.6 K (+3.92 %) |
| Mar 05 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.20 | 11,160 | 24,552 | 225,725 | 214.6 K to 225.7 K (+5.20 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 25,000 | 280,450 | 470,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 20,000 | 224,370 | 294,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 8,000 | 89,748 | 274,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 24,000 | 269,244 | 266,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.16 | 64 | 138 | 139,615 | 139.6 K to 139.6 K (+0.05 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.14 | 98 | 210 | 139,551 | 139.5 K to 139.6 K (+0.07 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 485,000 | 5,440,973 | 3,597,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 388,000 | 4,352,778 | 15,055,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 182,000 | 2,041,767 | 14,667,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 546,000 | 6,125,301 | 14,485,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.16 | 1,248 | 2,693 | 3,487,000 | 3.5 M to 3.5 M (+0.04 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.14 | 2,199 | 4,709 | 3,485,752 | 3.5 M to 3.5 M (+0.06 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 64,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 335,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 1,000 | 11,219 | 333,000 |